With no deals on calendar, IPO market is about to enter its typical February lull, when companies pause listing plans to focus on producing audited year-end financials. Read more here.

By Arasu Kannagi Basil Feb 12 (Reuters) - PayPay publicly filed its paperwork for a U.S. initial public offering on Thursday, as the SoftBank-backed Japanese payments app moves ahead with its highly ...

SoftBank Group Corp.’s digital payments provider PayPay Corp. has filed publicly for a US IPO, in what could be the biggest ...

PayPay is the latest international fintech to signal entry into the U.S. fintech investor market with an IPO that has been planned by SoftBank for years.

Wearable defibrillator maker Kestra Medical went public in March 2025, not long after automated insulin pump maker Beta ...

On February 12, PayPay submitted its filing for a U.S. initial public offering, advancing with its highly anticipated stock ...

PayPay Corp., a Japanese digital payment platform backed by SoftBank ( SFTBY) ( SFTBF ), filed its preliminary prospectus for ...

Medline discloses higher profit, revenue in first half of 2025 IPO could reportedly value healthcare giant at $50 billion PE-owned Medline could raise $5 billion Oct 28 (Reuters) - Medline disclosed ...

Grayscale dropped its public IPO filing with the U.S. Securities and Exchange Commission on Thursday, thanks to a confidence boost from so-called crypto president Donald Trump. Sadly, the filing also ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to ...

SoftBank-backed PayPay has taken a major step toward the public markets, making public its paperwork for a US initial public ...

The change is expected to be part of a wide-ranging market consultation paper to be published by Hong Kong Exchanges & Clearing Ltd as soon as the end of February.